Phase 3 Randomized 3-Month Trial with an Ongoing 3-Month Safety Extension of Fixed-Combination Brinzolamide 1%/Brimonidine 0.2%

Lignende værker

• Six-month results from a Phase III randomized trial of fixed-combination brinzolamide 1% + brimonidine 0.2% versus brinzolamide or brimonidine monotherapy in glaucoma or ocular hypertension
  af: Whitson, Jess T, et al.
  Udgivet: (2013)
• Fixed-combination brinzolamide 1%/brimonidine 0.2% vs monotherapy with brinzolamide or brimonidine in patients with open-angle glaucoma or ocular hypertension: results of a pooled analysis of two phase 3 studies
  af: Realini, T, et al.
  Udgivet: (2013)
• Clinical effectiveness of brinzolamide 1%–brimonidine 0.2% fixed combination for primary open-angle glaucoma and ocular hypertension
  af: Sharma, Sourabh, et al.
  Udgivet: (2015)
• Brinzolamide/Brimonidine Fixed Combination: Simplifying Glaucoma Treatment Regimens
  af: Moosavi, Reza, et al.
  Udgivet: (2018)
• Evaluation of the Use of Brinzolamide-Brimonidine Fixed Combination in Maximum Medical Therapy
  af: Oya Tekeli, et al.
  Udgivet: (2022-08-01)